Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 1.4% - Should You Sell?
Merck & Co., Inc. (MRK) saw its stock price drop 1.4% on Tuesday, trading at $119.67. This dip comes amidst positive developments like strong Keytruda clinical results and an AI collaboration with Tempus, but also concerns about Keytruda’s patent expiration which accounts for 55% of pharma sales. Analysts have a “Moderate Buy” consensus with an average price target of $125.88, while the company reported strong Q4 earnings and announced a quarterly dividend of $0.85.